Dr. Susan C. Modesitt, MD

Dr. Modesitt practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Modesitt's NPI, 1427070598, was assigned on July 24, 2006. Dr. Modesitt graduated from University of Virginia School of Medicine in 1995. Dr. Modesitt holds Georgia license 91037.

Dr. Modesitt's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Modesitt's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Modesitt is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Modesitt to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Modesitt practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Modesitt's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dmand AI has Dr. Modesitt's licenses on file in 2 states: Georgia and Virginia.

CMS data shows 332 Medicare services from Dr. Modesitt across 4 procedure codes in 2024, all of them office visits, for 98 Medicare patients. Medicare paid $31,465 for them.

CMS counts 98 Medicare patients who saw Dr. Modesitt in 2024. The largest group is 65 to 74, with 57 patients. 70% of them have high blood pressure, and 70% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Modesitt's median patient age at 69, with 98% women.

In 2024, Dr. Modesitt wrote 383 Medicare Part D claims for 70 patients. 87% of them were for generic drugs. CMS names the drug for 266 of them, across 10 drugs with 11 or more claims each, at $250,165 in total drug cost. In 2023, CMS named 213 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Modesitt for performance year 2024, reported through an alternative payment model (APM). Dr. Modesitt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Modesitt as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 8 general payments to Dr. Modesitt from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 90% of the total. Eisai Inc. paid the most, $3,260.

Dr. Modesitt graduated from University of Virginia School of Medicine in 1995.